Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

Pencil 50 - Philippines FDA Drug Approval Details

Approvals/Philippines FDA/Pencil 50

Approved

STANDARD

Pencil 50

Cadila Healthcare Limited🇵🇭 Food and Drug Administration - Philippines

Approval Date: Jul 14, 2025
Approval ID: 0fd7989bc3d1a9fe
Company: Cadila Healthcare Limited
Type: Standard

Approval Details

Approval Id: 0fd7989bc3d1a9fe
Drug Approval Philippines Name: Pencil 50
Product Name: Pencil 50
Registration Number: DRP-4555
Brand Name: Pencil 50
Generic Name: Cilostazol
Dosage Form: Tablet
Dosage Strength: 50 mg
Manufacturer: Cadila Healthcare Limited
Importer: Ambica International Corporation
Distributor: Kaufmann Pharma Inc.
Company Detail Path: /organization/cadila-healthcare-ltd
Issuance Date: 28 February 2022
Expiry Date: 09 December 2027
Pharmacologic Category: Platelet Aggregation Inhibitor
Classification: Prescription Drug (RX)

Active Ingredients

Approved

Quick Info

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

0fd7989bc3d1a9fe

Type

Standard

Back to Philippines FDA Approvals